Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

MARCH8 protein blocks HIV-1 infection

July 22, 2014

Japan Tobacco describes new HIV integrase inhibitors

July 22, 2014

ImQuest Pharmaceuticals receives FDA approval to initiate trials of IQP-0528 gel

July 18, 2014

Researchers at Rockefeller University patent new modified anti-CD4 MAbs

July 18, 2014

Merck & Co. patents novel HIV integrase inhibitors

July 16, 2014

Merck & Co. prepares new HIV vaccines

July 4, 2014

EMA committee recommends approval of Triumeq

July 1, 2014

FDA accepts Merck & Co.'s NDA for fixed-dose raltegravir and lamivudine

June 26, 2014

Irish and Belgian university researchers report novel HIV-1 RT inhibitors

June 18, 2014

ViiV Healthcare and Janssen to develop single-tablet regimen for HIV

June 16, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...